My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Cross-talk between iron metabolism and diabetes.

    Fernández-Real JM, López-Bermejo A, Ricart W.

    Diabetes. 2002 Aug;51(8):2348-54. Review.PMID: 12145144 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cross talk between iron metabolism and diabetes.

    Tilbrook L.

    Ann Clin Biochem. 2004 May;41(Pt 3):255. No abstract available. PMID: 15154398 [PubMed - indexed for MEDLINE]Related articles

    3.

    The potential biological mechanisms of arsenic-induced diabetes mellitus.

    Tseng CH.

    Toxicol Appl Pharmacol. 2004 Jun 1;197(2):67-83. Review.PMID: 15163543 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.

    Van Campenhout A, Van Campenhout C, Lagrou AR, Abrams P, Moorkens G, Van Gaal L, Manuel-y-Keenoy B.

    Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):444-54.PMID: 16506275 [PubMed - indexed for MEDLINE]Related articles

    5.

    Oral antidiabetic agents: current role in type 2 diabetes mellitus.

    Krentz AJ, Bailey CJ.

    Drugs. 2005;65(3):385-411. Review.PMID: 15669880 [PubMed - indexed for MEDLINE]Related articles

    6.

    Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses.

    Martinka E, Galajada P, Ochodnicky M, Lichardus B, Straka S, Mokan M.

    Med Hypotheses. 1997 Sep;49(3):271-5.PMID: 9293472 [PubMed - indexed for MEDLINE]Related articles

    7.

    Review article: diabetes and atherosclerosis--running on a common road.

    Federici M, Lauro R.

    Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:11-5. Review.PMID: 16225464 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

    Woodman RJ, Chew GT, Watts GF.

    Drugs. 2005;65(1):31-74. Review.PMID: 15610050 [PubMed - indexed for MEDLINE]Related articles

    9.

    Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

    Yu Y, Suo L, Yu H, Wang C, Tang H.

    Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

    10.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [And what about diabetes?]

    Cerasi E.

    Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French. PMID: 18225448 [PubMed - indexed for MEDLINE]Related articles

    12.

    Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.

    Li XC, Zhuo JL.

    Clin Sci (Lond). 2007 Aug;113(4):183-93. Review.PMID: 17623014 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    C-peptide, Na+,K(+)-ATPase, and diabetes.

    Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.

    Exp Diabesity Res. 2004 Jan-Mar;5(1):37-50. Review.PMID: 15198370 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies.

    Tenenbaum A, Fisman EZ.

    Am J Cardiovasc Drugs. 2004;4(5):269-80. Review.PMID: 15449970 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications.

    Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L.

    Curr Med Chem. 2009;16(1):113-29. Review.PMID: 19149565 [PubMed - indexed for MEDLINE]Related articles

    16.

    Microvascular permeability in diabetes and insulin resistance.

    Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, Wu MH.

    Microcirculation. 2007 Jun-Jul;14(4-5):363-73. Review.PMID: 17613808 [PubMed - indexed for MEDLINE]Related articles

    17.

    Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.

    D'Souza RF, Feakins R, Mears L, Sabin CA, Foster GR.

    Aliment Pharmacol Ther. 2005 Mar 1;21(5):519-24.PMID: 15740534 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.

    Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF.

    Diabetes. 2004 Mar;53(3):645-53.PMID: 14988248 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus.

    Mohamed-Ali V, Pinkney J.

    Treat Endocrinol. 2002;1(6):399-410. Review.PMID: 15832492 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glucose effectiveness: measurement in diabetic and nondiabetic humans.

    Basu A, Rizza RA.

    Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S157-65. Review.PMID: 11460567 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity